Table 3 Changes in blood parameters prior to, at two and six months of treatment
Variables | Groups | |||
|---|---|---|---|---|
Zinc | Vitamin A | Zinc+ Vit A | Placebo | |
Plasma CRP (mg/L), median (IQR) | ||||
0 month | 25.7 (13.7-38.8) | 27.9 (11.5-42.1) | 29.1 (12.6-43.0) | 30.9 (13.3-47.4) |
2 month | 4.6 (1.4-13.8) ‡ | 4 (1-14.3)‡ | 4.2 (1.3-15.5) ‡ | 6.4 (1.5-14.6) ‡ |
6 month | 1.3 (0.5-2.7)‡ | 1.5(0.6-3.3)‡ | 1.1 (0.5-4.4) ‡ | 1.7 (0.9-40)‡ |
Serum albumin (g/dL), mean ± SD | ||||
0 month | 3.8 ± 0.84 | 4.0 ± 0.75 | 4.0 ±0.96 | 3.8 ± 0.83 |
2 month | 4.5 ± 0.68‡ | 4.3 ± 0.88† | 4.4 ± 0.74 | 4.4 ± 0.78‡ |
6 month | 4.6 ± 0.52‡ | 4.6 ± 0.72‡ | 4.7 ± 0.62‡ | 4.6 ± 0.52‡ |
Leukocytes(cells/mm3),median (IQR) | ||||
0 month | 9300 (7575-13000) | 9750 (7775-11575) | 10200 (7475-12250) | 9750 (7000-2225) |
2 month | 6700 (5400-8100)‡ | 6600 (5600-8050)‡ | 7500 (5500-8875)‡ | 7300 (5900-9100)‡ |
6 month | 6000 (5100-7000)‡ | 6900(5275-8100)‡ | 6800 (5850-7800)‡ | 6800(5800-8100)‡ |
ESR (mm),median (IQR) | ||||
0 month | 73.0 (48.0-99.5) | 59.5 (40.0-88.5) | 62.0 (36.0-92.0) | 75.0 (42.0-109.0) |
2 month | 28 (16-40)‡ | 31 (18-40)‡ | 30 (17.3-38.8)‡ | 28 (16-45)‡ |
6 month | 11 (4-28)‡ | 14 (8-28.8)‡ | 12 (6-28)‡ | 11 (8-28)‡ |
Hemoglobin(g/dL), mean ± SD | ||||
0 month | 11.2 ± 2.7 | 11.6 ± 2.4 | 11.6 ± 2.5 | 11.0 ± 2.5 |
2 month | 12.5 ± 2.78‡ | 12.6 ± 2.55‡ | 13.18 ± 2.48‡ | 12.12 ± 2.43‡ |
6 month | 12.8 ± 2.3‡ | 13.0 ± 2.2‡ | 13.3 ± 2.2‡ | 12.8 ± 2.3‡ |
Plasma zinc(μmol/L), mean ± SD | ||||
0 month | 11.6 ± 2.2 | 11.9 ± 3 | 12.1 ± 3.0 | 11.8 ± 2.4 |
2 month | 11.7 ± 2.43† | 11.6 ± 1.83‡ | 12.5 ± 2.33‡ | 11.7 ± 2.33‡ |
6 month | 13.1 ± 1.92† | 12.5 ± 2.1† | 12.8 ± 2.9† | 12.6 ± 1.7 3‡ |
Plasma retinol(μmol/L), median (IQR) | ||||
0 month | 0.7(0.5-1.0) | 0.7(0.5-1.5) | 0.7(0.4-1.1) | 0.7 (0.5-1) |
2 month | 1.2 (1-1.6)a‡ | 1.5(1-2)ab‡ | 1.3 (1-1.9)‡ | 1.2 (0.9-1.6)b‡ |
6 month | 1.4 (1.1-1.9)† | 1.6 (1.2-2.0)‡ | 1.6 (1.2-1.9) | 1.4 (1.0-1.8)‡ |